Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2011-02-22
2011-02-22
Hama, Joanne (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S325000, C435S372000
Reexamination Certificate
active
07892829
ABSTRACT:
Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
REFERENCES:
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5591625 (1997-01-01), Gerson et al.
patent: 6099832 (2000-08-01), Mickle et al.
patent: 94/00484 (1994-01-01), None
patent: 96/30331 (1996-10-01), None
patent: 99/03973 (1999-01-01), None
patent: 99/49015 (1999-09-01), None
Prockop Science 276:71-74, 1997.
Gerson, S. Nature Medicine 5:262-264, 1999.
Saadi et al. Life Sciences 62:365-387, 1998.
Ott et al. Basic Res. Cardiol. 100:504-517; 2005.
Jorgensen et al. Curr. Opinion Biotech. 15:406-410; 2004.
Breitbach et al. Blood 110:1362-1369; 2007.
European Search Report corresponding to European Patent Application Serial No. 03776501.3-1222; dated Oct. 19, 2009.
Martin et al., “Allogenic mesenchymal stem cell engraftment in the infarcted rat heart: Timing and delivery route.” Bone Marrow Transplantation, vol. 29, No. S2, Mar. 2002, XP002549207.
Written Opinion in PCT/US98/14520, dated Jun. 23, 1999.
International Search Report in PCT/US98/14520, dated Oct. 13, 1998.
Gordon Stephen L.
Mackay Alastair Morgan
Martin Bradley J.
Pittenger Mark F.
Hama Joanne
McAndrews Held & Malloy Ltd.
Osiris Therapeutics, Inc.
LandOfFree
Cardiac muscle regeneration using mesenchymal stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac muscle regeneration using mesenchymal stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac muscle regeneration using mesenchymal stem cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2647167